4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-047983
Chairman and CEO bought 5,200 shares at an average $1.47 ($7,655)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-07-21 | Purchase | +3,100 | $1.46 | $4,526 | 10,800,871 | D |
| Niihara Yutaka Chairman and CEO | 2021-07-22 | Purchase | +1,000 | $1.49 | $1,490 | 10,801,871 | D |
| Niihara Yutaka Chairman and CEO | 2021-07-23 | Purchase | +1,100 | $1.49 | $1,639 | 10,802,971 | D |
| Open-market purchases · 5,200 sh · avg $1.47 · $7,655 | |||||||
Loading xslF345X03/doc4.xml…